Fc variants with altered binding to FcRn

Details for Australian Patent Application No. 2008319144 (hide)

Owner Xencor, Inc.

Inventors Chamberlain, Aaron; Desjarlais, John Rudolph; Karki, Sher Bahadur; Dahiyat, Bassil

Agent Davies Collison Cave

Pub. Number AU-A-2008319144

PCT Pub. Number WO2009/058492

Priority 11/932,151 31.10.07 US

Filing date 22 September 2008

Wipo publication date 7 May 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058492 Priority application(s): WO2009/058492

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319145-Prostaglandin analog compositions and methods to treat epithelial-related conditions

2008319130-Methods and device for the detection of occult blood